{"id":"W2970753093","doi":"10.1111/dmcn.14336","title":"Rituximab in children with myelin oligodendrocyte glycoprotein antibody and relapsing neuroinflammatory disease","year":2019,"lang":"en","type":"article","venue":"Developmental Medicine & Child Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Mental Health Research Canada; Hospital for Sick Children","funders":"Juno Therapeutics; Office of Information and Resource Management; Ontario Institute for Regenerative Medicine; Hospital for Sick Children; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Stem Cell Network; Guthy-Jackson Charitable Foundation; Biogen; National Multiple Sclerosis Society","keywords":"Rituximab; Medicine; Myelin oligodendrocyte glycoprotein; Tolerability; Interquartile range; Internal medicine; Hypogammaglobulinemia; Immunology; Adverse effect; Population; Gastroenterology; Antibody; Central nervous system; Myelin","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000862272,0.0003961169,0.0007488307,0.0006420586,0.0003903658,0.0005084944,0.0003362369,0.0005660292,0.0005126352],"category_scores_gemma":[0.003274369,0.0002934347,0.0005377362,0.0007812551,0.00043524,0.0005056016,0.0004054281,0.0004946893,0.0001536195],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005182516,"about_ca_system_score_gemma":0.0005097812,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003614723,"about_ca_topic_score_gemma":0.003285092,"domain_scores_codex":[0.9987255,0.0004448121,0.0001675698,0.0002409395,0.0002284292,0.0001927206],"domain_scores_gemma":[0.9977025,0.0005083381,0.001346774,0.00006135994,0.0001178282,0.0002631307],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001906849,0.00003893589,0.9965338,0.00002073517,0.00003244577,0.00120058,0.0001316761,0.00003269214,0.0002927461,0.000008289993,0.00004958944,0.001467854],"study_design_scores_gemma":[0.00002902724,0.0007943484,0.9883244,0.00002233816,0.00005674332,0.009695546,0.000424895,0.0001016799,0.000165675,0.00001460194,0.0003641017,0.000006775963],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9990138,0.0007379892,0.00003808993,0.00001994456,0.000002957657,0.000006503889,0.00005924799,0.000002219077,0.0001191581],"genre_scores_gemma":[0.999313,0.0003775981,0.00008471664,0.00003711982,0.00001369736,0.00001001483,0.0001316657,0.000002000344,0.00003029524],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003614723,"threshold_uncertainty_score":0.007187366,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009899801132007226,"score_gpt":0.2598854004850446,"score_spread":0.2499855993530374,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}